Syros Pharmaceuticals, Inc.

NASDAQ:SYRS

2.61 (USD) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019201820172016201520142013
Assets:
Current Assets:
Cash & Cash Equivalents 139.526167.46792.302173.98441.44149.88632.20558.58835.90960.3933.801
Short Term Investments 034.83738.067049.97549.79339.84425.005000
Cash and Short Term Investments 139.526202.304130.369173.98491.41699.67972.04983.59335.90960.3933.801
Net Receivables 01.6942.9792.33120.158000.867000
Inventory 00000.29000000
Other Current Assets 5.4547.3943.2372.2422.6491.4170.9171.0480.540.150.112
Total Current Assets 144.98211.392136.585178.557114.513101.73473.15985.50836.44960.5433.913
Non-Current Assets:
Property, Plant & Equipment, Net 19.48324.6627.28529.64131.8893.8613.9384.854.7990.8810.938
Goodwill 00000000000
Intangible Assets 00000000000
Goodwill and Intangible Assets 00000000000
Long Term Investments 2.1193.08613.0383.0863.0860.290.290.4830.48300
Tax Assets 00000000000
Other Non-Current Assets 1.5925.3486.0271.9660.490.8811.1010.4821.90.070.07
Total Non-Current Assets 23.19433.09446.3534.69335.4655.0325.3295.8157.1820.9511.008
Total Assets 168.174244.486182.935213.25149.978106.76678.48891.32343.63161.4944.921
Liabilities & Equity:
Current Liabilities:
Account Payables 11.5446.4113.6923.6035.8533.3092.2832.4155.0350.9280.594
Short Term Debt 8.9912.0712.0111.7281.2780.0090.0470.1680.13300
Tax Payables 00000000000
Deferred Revenue 04.3310.18112.2095.7391.9260.3550.55000
Other Current Liabilities 16.14617.96615.62411.08410.64614.2859.7286.4342.7880.3240.316
Total Current Liabilities 36.68130.77831.50828.62423.51619.52912.4139.5677.9561.2520.91
Non-Current Liabilities:
Long Term Debt 34.55661.563.1864.48524.6390.0220.0060.0530.20600
Deferred Revenue Non-Current 0009.87722.6398.27600000
Deferred Tax Liabilities Non-Current 0000-22.639-0.02200000
Other Non-Current Liabilities 80.27524.4723.02919.71122.6390.3750.7451.1011.420.0010
Total Non-Current Liabilities 114.83185.97266.20994.07347.2788.6510.7511.1541.6260.0010
Total Liabilities 151.512116.7597.717122.69770.79428.1813.16410.7219.5821.2530.91
Equity:
Preferred Stock 000000091.32382.01382.01313.266
Common Stock 0.0260.020.0610.0560.0430.0340.0260.0230.0020.0010.005
Retained Earnings -722.807-558.233-463.579-377.021-292.983-217.545-155.266-101.256-53.513-23.695-10.264
Accumulated Other Comprehensive Income/Loss 00.102-0.07900.024-0.003-0.042-0.009-0.931-0.4280
Other Total Stockholders Equity 739.443685.847548.815467.518372.1296.1220.60690.5216.4782.350.966
Total Shareholders Equity 16.662127.73685.21890.55379.18478.58665.32480.60234.04960.2413.973
Total Equity 16.662127.73685.21890.55379.18478.58665.32480.60234.04960.2413.973
Total Liabilities & Shareholders Equity 168.174244.486182.935213.25149.978106.76678.48891.32343.63161.4944.883